A drug used to sedate patients before painful procedures could be the next big development in antidepressant alternatives to Zoloft. A study presented at the American Psychiatric Association’s yearly meeting found that the anesthetic ketamine has lasting effects that treat depression quickly in patients who did not respond to selective serotonin reuptake inhibitors (SSRIs) like Zoloft.
Though doctors are still uncertain how to utilize ketamine when treating common depression patients, many express hope that the drug could treat depression faster while avoiding dangerous SSRI antidepressant side effects. Studies have revealed that Zoloft side effects can affect a wide range of patients, including pregnant women.
Children born to women who take Zoloft during pregnancy are at an increased risk of Zoloft birth defects, including heart defects, brain defects, anencephaly and omphalocele. Thousands of women have filed Zoloft lawsuits alleging that the drug’s manufacturer failed to adequately warn doctors and patients of the increased risks associated with the drug.